In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.
SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnological company focused on treating inflammation through resolution therapy, today announced that it has initia ...
Your watch’s VO2 max isn’t perfect, but you can improve its accuracy with better data and heart-rate tracking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results